Opinion Article
Da-Yong Lu
Abstract
Personalized cancer treatment (PCT) has a long history— dating back to 1950s in US. It is a multidisciplinary approach pioneered with in vitro drug sensitivity testing (DST). PCT are widely investigated within 1970s and popularized since then. Despite widely utility, PCT remains to be diversified and perfected in a new era. Central dogma remains to be found out. This article tries to introduce the different characters of PCT and deliver our vision of PCT in future.